Use of direct oral anticoagulants in ICU patients. Part I – Applied pharmacology

Abdul Wahab; Rupali Patnaik; Mohan Gurjar

doi:10.5114/ait.2021.110607

eISSN: 1731-2531
ISSN: 1642-5758

Anaesthesiology Intensive Therapy

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Open access

Journal integrated with

5/2021
vol. 53

Send email

Copy url:

abstract:

Review paper

Use of direct oral anticoagulants in ICU patients. Part I – Applied pharmacology

Abdul Wahab

¹

,

Rupali Patnaik

²

,

Mohan Gurjar

²

University of Iowa Hospitals and Clinics, Iowa City, United States
Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, Uttar Pradesh, India

Anaesthesiol Intensive Ther 2021; 53, 5: 429–439

DOI: https://doi.org/10.5114/ait.2021.110607

Online publish date: 2021/11/24

View full text Get citation

PlumX metrics:

Direct oral anticoagulants (DOACs) have revolutionized the field of anticoagulation in the last decade, mainly due to their fixed dosing, rapid onset of anticoagulant effect, and non-inferiority to vitamin K antagonists for both efficacy and safety. Also, the availability of specific and non-specific reversal agents makes these drugs popular. However, in critically ill patients, significant alterations in drug pharmacokinetics and pharmacodynamics might occur due to various ongoing pathophysiological derangements like decreased gastrointestinal absorption, increased volume of distribution, and impaired renal and/or hepatic function. Insight into these changes is essential regarding the safe and effective use of DOACs in critically ill patients. The current article is a narrative review on the use of DOACs in intensive care unit patients, covering ‘Applied pharmacology’; the second article in the series covers ‘Clinical evidence’.

keywords:

Use of direct oral anticoagulants in ICU patients. Part I – Applied pharmacology

Abdul Wahab 1 , Rupali Patnaik 2 , Mohan Gurjar 2

intensive care unit, pharmacokinetics, critically ill, renal dysfunction, drug-drug interaction, oral anticoagulant

Abdul Wahab

¹

,

Rupali Patnaik

²

,

Mohan Gurjar

²